Human and murine IL2 receptors differentially respond to the human-IL2 component of immunocytokines

The humanized immunocytokine, hu14.18-IL2 (ICp), leads to the immune cell-mediated destruction of GD2-expressing tumors in mouse models, resulting in potent antitumor effects with negligible IL2-related toxicity. In contrast, when ICp is used clinically, antitumor activity is accompanied by dose-lim...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncoimmunology
Auteurs principaux: Perez Horta, Zulmarie, Saseedhar, Swetha, Rakhmilevich, Alexander L., Carmichael, Lakeesha, Hank, Jacquelyn A., Boyden, Margaret, Gillies, Stephen D., Sondel, Paul M.
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2018
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6492958/
https://ncbi.nlm.nih.gov/pubmed/31069147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1238538
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires